Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Anales De Pediatria|July 24, 2018
[Controversies in the treatment of paediatric immune thrombocytopenia]Rubén Berrueco, José Luis Dapena, Elena Sebastián, et al.Anales De Pediatria|September 25, 2020
[Autoimmune hemolytic anemia: Case review]Nazaret Sánchez, Josune Zubicaray, Elena Sebastián, et al.BMJ Case Reports|September 4, 2020
Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challengeIrene Alejandra Orbe Jaramillo, Carmen De Lucas Collantes, Amelia Martínez de Azagra, et al.Anales De Pediatria|July 11, 2021
Management of primary immune thrombocytopenia. A comparison between two historical cohortsSandra Fernández-Plaza, Jesús González de Pablo, Eva Gálvez, et al.Acta Paediatrica (Oslo, Norway : 1992)|January 18, 2021
Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centresRubén Berrueco, Elena Sebastián, María Solsona, et al.British Journal of Clinical Pharmacology|May 2, 2022
Tapering of the thrombopoietin receptor agonist in paediatric patients with chronic immune thrombocytopenia: Is it possible?María Solsona, Rubén Berrueco, Elena Sebastián, et al.Atencion Primaria|February 16, 2013
[Training evaluation using the four courses portfolio in primary care residents of a Teaching Unit in Murcia]José Saura Llamas, María Nieves Martínez Garre, María Elena Sebastián Delgado, et al.European Journal of Haematology|July 19, 2012
Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myelomaNoemí Puig, María E Sarasquete, Miguel Alcoceba, et al.Laboratory Medicine|March 21, 2022
Value of Thyroid Peroxidase Antibodies in Neuroimmune Diseases: Analysis of Interference During Treatment with Intravenous ImmunoglobulinsMaría Jiménez-Legido, Verónica Cantarín-Extremera, María Eugenia López-Guio, et al.Annals of Hematology|September 8, 2012
The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myelomaNoemí Puig, María E Sarasquete, Miguel Alcoceba, et al.Pageof 4